Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Milk proteins represent a complex and heterogeneous group of bioactive molecules categorized into two primary fractions: caseins (comprising alpha-s1, alpha-s2, beta, and kappa variants) and whey proteins (including alpha-lactalbumin, beta-lactoglobulin, and lactoferrin) [5, 14]. Caseins typically associate into large colloidal micelles that serve as essential sources of amino acids, phosphate, and calcium for mammalian development [13, 14]. Whey proteins provide a broad range of physiological benefits, including potent antimicrobial, antioxidant, and immunomodulatory activities [6, 18]. Clinically, these proteins are most notable as the primary allergens in Cow's Milk Protein Allergy (CMPA), where they trigger IgE-mediated immune responses in a significant percentage of the pediatric population [2, 15]. In therapeutic contexts, milk proteins are used as antigens in oral immunotherapy (OIT) to desensitize allergic individuals by shifting the immune response from a Th2-mediated allergic state to a state of peripheral tolerance [8, 22]. Additionally, specific components such as bovine lactoferrin are under investigation for their potential to inhibit viral pathogens, including SARS-CoV-2, by interfering with viral attachment and entry into host cells [4, 12, 16].
Milk proteins act as exogenous antigens in oral immunotherapy (OIT) to induce peripheral tolerance by promoting the expansion of allergen-specific regulatory T cells (Tregs) and increasing the production of blocking antibodies such as IgG4 and IgA [3, 9, 21]. Specific bioactive components like lactoferrin exhibit antimicrobial and antiviral activity by sequestering iron, binding to viral glycoproteins (e.g., SARS-CoV-2 spike protein), or blocking host cell receptors like heparan sulfate proteoglycans [4, 12, 16]. Additionally, bioactive peptides released during milk protein digestion, such as casokinins, can inhibit the angiotensin-converting enzyme (ACE), exerting antihypertensive effects [14, 20].
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Milk proteins (CMP).